Market cap
$14,047 Mln
Revenue (TTM)
$681 Mln
P/E Ratio
--
P/B Ratio
12.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 13.74 | 51.49 | 47.27 | 102.71 | 545.76 |
| EBIT | 25.11 | 14.37 | 26.68 | 16.74 | 4.42 |
| Net Profit | 35.86 | 40.92 | 46.54 | 20.21 | 8.37 |
| EPS | 34.22 | 44.84 | 50.18 | 21.47 | 11.57 |
| Book Value | -- | -- | 81.30 | 29.49 | 25.85 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -70.07 | -379.02 | -- | -34.32 | -105.82 |
| Net Margin
| -99.90 | -429.73 | -- | -- | -99.90 |
| Return on equity
| -26.23 | -36.97 | -8.58 | -22.39 | -47.72 |
| Return on Capital
| -25.32 | -35.30 | -8.42 | -21.75 | -45.78 |
| Return on Assets
| -22.38 | -32.22 | -7.13 | -18.84 | -41.18 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.03 | 0.03 |
Profitability
ROCE
-8.42
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
-8.42
|
-21.75
|
-45.78
|
-50.32
|
-50.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-8.58
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
-8.58
|
-22.39
|
-47.72
|
-52.87
|
-53.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-7.13
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
-7.13
|
-18.84
|
-41.18
|
-47.07
|
-46.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
--
|
-34.32
|
-105.82
|
-349.65
|
-1,026.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-10.97
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
-10.97
|
-30.08
|
-99.90
|
-341.19
|
-848.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.47
--
Year on year growth in net sales
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
0.47
|
0.86
|
2.05
|
2.63
|
370.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
--
|
39.54
|
7.72
|
-23.55
|
-50.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
46.54
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
46.54
|
45.49
|
9.81
|
-25.16
|
-53.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.50
--
Year on year growth in earnings per share
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
0.50
|
0.46
|
0.22
|
-0.23
|
-0.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
0.01
|
0.03
|
0.03
|
0.06
|
0.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
0.00
|
0.01
|
0.01
|
0.02
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.36
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
6.36
|
5.41
|
8.87
|
8.76
|
18.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
6.23
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
6.23
|
5.31
|
8.58
|
8.61
|
18.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
--
|
--
|
-35.74
|
-135.95
|
-48.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
24.45
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
24.45
|
24.55
|
30.18
|
24.67
|
47.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.65
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
0.65
|
0.63
|
0.40
|
0.14
|
0.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
75.24
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
75.24
|
74.41
|
69.89
|
69.11
|
90.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
121.60
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
121.60
|
192.49
|
284.69
|
341.05
|
1,360.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
120.31
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
120.31
|
118.23
|
170.50
|
322.60
|
1,245.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
76.54
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
76.54
|
148.66
|
184.08
|
87.56
|
204.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-115.34
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
-115.34
|
-49.37
|
-19.57
|
-15.01
|
-11.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
7.50
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
7.50
|
11.66
|
7.64
|
10.20
|
3.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-65.36
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Intracellular Th (ITCI)
|
-65.36
|
-40.38
|
-16.89
|
-13.60
|
-8.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|